X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER

期刊標題檢索 CANCER-AM CANCE 最新評論: Submission begins on October 23, 2024, please make a note. (2024-10-23)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER]您好,您是該頁面的第 148385 位訪客。

期刊簡介
期刊名稱CANCER CANCER
LetPub Score
7.9
50 ratings
Rate

Reputation
8.8

Influence
7.2

Speed
7.8

期刊簡稱CANCER-AM CANCER SOC
ISSN0008-543X
E-ISSN1097-0142
h-index277
CiteScore
CiteScoreSJRSNIPCiteScore Rank
13.102.8872.021
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q139 / 404
Category: Medicine
Subcategory: Cancer Research
Q133 / 230

自引率 (2023-2024)1.60%自引率趨勢
掲載範囲
The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society.

CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142
在線稿件提交https://mc.manuscriptcentral.com/cancer
開放訪問No
出版商John Wiley and Sons Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月2回刊行
創刊年0
每年文章數369每年文章數趨勢
黃金OA百分比20.09%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ149/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-543X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Very fast, 2-3 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【CANCER】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS331021
    CANCER RESEARCH312135
    BMC CANCER245511
    Asian Pacific Journal of Cancer Prevention219241
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198016
    INTERNATIONAL JOURNAL OF CANCER191631
    CLINICAL CANCER RESEARCH181667
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176439
    ONCOLOGY REPORTS175032
    CA-A CANCER JOURNAL FOR CLINICIANS163632
  •  

    CANCER CANCER
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [CANCER] 的評論撰寫評論
作者: Uranium


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 10:36:04 評論於
Submission begins on October 23, 2024, please make a note.
(0) 讚! | Uranium

作者: 龙鳞之雁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-17 22:05:47 評論於
May I ask how long it usually takes for Xiao Xiu to get results back? It's been almost a week.
(0) 讚! | 龙鳞之雁

作者: 鲍德温艾伦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-23 12:37:11 評論於
I urinated on the first day, which I also found strange.
(0) 讚! | 鲍德温艾伦

作者: 半莲酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-29 17:55:38 評論於
The submission was under review the second day, is this the editor's internal review?
(0) 讚! | 半莲酱吖

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-28 23:41:22 評論於
This is related to the amount of manuscripts and editors in the editing department. It has been two months, you can email the editing department to inquire about the situation.
(0) 讚! | Adelaide Lawson

作者: 龙鳞之雁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-25 13:01:04 評論於
Could you please tell me why my application has been under review for almost 2 months? Is this normal?
(0) 讚! | 龙鳞之雁

作者: 明冠晴丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-22 16:48:10 評論於
Is the original article limited to 3500 words? Why are some already published articles nearly 4000 words long?
(0) 讚! | 明冠晴丽

作者: 璃沙友易


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-28 18:10:13 評論於
Review speed: 2.0 | Submission acceptance rate: 75.0
Research focus: Oncology
Experience sharing: I chose the oncology section of the urological and reproductive system tumors. The editor was very friendly, and my paper was under review on the second or third day. I made minor revisions twice. The first round of revisions involved suggestions from two reviewers, which were not difficult to address. If there were points that could not be supplemented, I politely explained in the limitation section. The second round of revisions required polishing, so I decided to use the editing services offered by Wiley, the publisher of CANCER journal. It took about 1.5 months from submission to acceptance. Overall, I would recommend submitting your work for consideration. My retrospective study on a rare type of cancer had some novelty to it, and the editor took it into consideration
(0) 讚! | 璃沙友易

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-06 20:33:11 評論於
How is the status of the article now?
(0) 讚! | 书生永寿

作者: 飞月庆彬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-13 22:06:34 評論於
I would like to ask, in what format should the form be uploaded? Should it be directly inserted into the article? And what format should the additional file for the form be in?
(0) 讚! | 飞月庆彬

作者: 飞月庆彬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-13 20:35:16 評論於
I didn't find the font size and table format on the official website. How did everyone change it?
(0) 讚! | 飞月庆彬

作者: 东风文华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-09 17:47:59 評論於
Will the submission be under review status after submission?
(0) 讚! | 东风文华

作者: 楠沁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-07 07:02:27 評論於
Please submit a clean copy of your main document. Currently, the file has tracked changes. Could you please guide me on how to modify it?
(0) 讚! | 楠沁

作者: 平原依凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-20 09:18:25 評論於
Looking back on the article, I think it has some new ideas
(0) 讚! | 平原依凝

作者: 良骥酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-21 22:54:57 評論於
Did you send the document?
(0) 讚! | 良骥酱大魔王

作者: 降龙树芬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-28 22:07:43 評論於
Can the OP share the rejection letter from CA? I have never seen how editors of such high-end magazines politely reject submissions
(0) 讚! | 降龙树芬

作者: 东风谷芬芬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-13 13:49:34 評論於
Please translate the following passage into English and Japanese, using ":" and ":" as headers
(0) 讚! | 东风谷芬芬

作者: 寒阴婷秀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-15 15:07:28 評論於
How did it go after you changed your major?
(0) 讚! | 寒阴婷秀

作者: 削月修兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-06 22:06:23 評論於
I just wanted to ask if you have ever experienced having your email bounced back when submitting a contribution, and being asked to modify the email?
(0) 讚! | 削月修兰

作者: 璃沙丁酉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-15 17:16:04 評論於
Review speed: 1.0 | Submission hit rate: 5.0 Emphasis on research direction: Cancer experience sharing: I submitted three times and all were desk rejections, it's really hard to accept. Although the impact factor is not high, why can't my articles catch the editor's eye, making me very frustrated. This recent rejection, the editor actually asked me to transfer to the prestigious journal CA: A Cancer Journal for Clinicians. CA has an IF of 286, clearly the gathering place for big shots, while CANCER has only 6.9, why should they accept your rubbish article? I really can't understand whether the editor is joking with me, but since he arranged for me to transfer in one click, I confirmed it. Just waiting for CA to reject it instantly.

Decision on Manuscript ID CNCR-22-301319-Dec-2022
Dear Dr. ******
Thank you for your recent manuscript submission of "*******************" (CNCR-22-3013) to Cancer. Your paper has undergone an initial review. Due to overall space constraints, only a limited number of papers can be published, and your paper did not receive a high enough priority score for publication in Cancer. However, your paper is a candidate for transfer to another journal published by Wiley. Please consider the journal option below, and if you would like us to transfer your manuscript and associated reviews (if your paper received reviews), please click the first link. CA: A Cancer Journal for Clinicians: To ACCEPT and AUTOMATICALLY TRANSFER your paper and any related reviews: *** PLEASE NOTE: This is a two-step process. After clicking on the link, you will be directed to a webpage to confirm. ***https://mc.manuscriptcentral.com/cancer?URL_MASK=bb5799***********************
(0) 讚! | 璃沙丁酉

作者: Yvonne Theresa


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-22 15:11:20 評論於
2-3 weeks
(0) 讚! | Yvonne Theresa

作者: Wendell Eliot


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-16 14:48:00 評論於
I would like to ask the seniors if the review process of this magazine is quick recently, my child is about to graduate soon. Thank you everyone!
(0) 讚! | Wendell Eliot

作者: 犬走良翰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-08 18:19:21 評論於
Really fast
(0) 讚! | 犬走良翰

作者: 南川文涛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-23 17:43:58 評論於
I also encountered it. Just send the JPEG directly
(0) 讚! | 南川文涛

作者: mafegqiu06


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-22 13:30:53 評論於
Excuse me, will there be any page fees in 2022?
(0) 讚! | mafegqiu06

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [CANCER] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*